Bone marrow-derived mesenchymal stem cells for Crohn's disease perianal fistula
This study aims to determine the safety of dose escalation of allogeneic bone marrow- derived mesenchymal stem cell (BM-MSCs) infusion for the treatment of fistula in Crohn's disease.
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells for Crohn's disease perianal fistula